UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.988

Sortiert nach

Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA

Annals of oncology, 2014-06, Vol.25 (6), p.1116-1121

2014

Link zum Volltext

Verfügbarkeit prüfen

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Annals of oncology, 2011-03, Vol.22 (3), p.515-523

2011

Link zum Volltext

Verfügbarkeit prüfen

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer

NPJ breast cancer, 2023-12, Vol.9 (1), p.99-99, Article 99

2023

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer

Annals of oncology, 2013-10, Vol.24 (10), p.2630-2635

2013

Link zum Volltext

Verfügbarkeit prüfen

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review

Journal of cancer research and clinical oncology, 2004, Vol.130 (1), p.1-7

2004

Link zum Volltext

Verfügbarkeit prüfen

Modifications of a conserved regulatory network involving INDEHISCENT controls multiple aspects of reproductive tissue development in Arabidopsis

The New phytologist, 2013-01, Vol.197 (1), p.73-87

2013

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

Annals of oncology, 2018-03, Vol.29 (3), p.646-653

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1318-1332

1997

Link zum Volltext

Verfügbarkeit prüfen

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

Breast cancer research and treatment, 2015-01, Vol.149 (1), p.163-169

2015

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

JNCI : Journal of the National Cancer Institute, 2004-04, Vol.96 (7), p.516-523

2004

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

JNCI : Journal of the National Cancer Institute, 2011-03, Vol.103 (6), p.478-488

2011

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

Breast cancer research and treatment, 2019-06, Vol.175 (3), p.595-603

2019

Link zum Volltext

Verfügbarkeit prüfen

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1333-1340

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of dasatinib and ixabepilone in patients with solid tumors

Investigational new drugs, 2013-02, Vol.31 (1), p.92-98

2013

Link zum Volltext

Verfügbarkeit prüfen

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Annals of oncology, 2017-04, Vol.28 (4), p.761-768

2017

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

Annals of oncology, 2005-08, Vol.16 (8), p.1297-1304

2005

Link zum Volltext

Verfügbarkeit prüfen

Altered Expression of SPINDLY Affects Gibberellin Response and Plant Development

Plant physiology (Bethesda), 2001-07, Vol.126 (3), p.1174-1185

2001

Link zum Volltext

Verfügbarkeit prüfen

The gar2 and rga Alleles Increase the Growth of Gibberellin-Deficient Pollen Tubes in Arabidopsis

Plant physiology (Bethesda), 2004-02, Vol.134 (2), p.694-705

2004

Link zum Volltext

Verfügbarkeit prüfen

Ductal Carcinoma In Situ, Complexities and Challenges

JNCI : Journal of the National Cancer Institute, 2004-06, Vol.96 (12), p.906-920

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trial

Annals of oncology, 2017-11, Vol.28 (11), p.2761-2767

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic analysis of gibberellin signal transduction

Plant physiology (Bethesda), 1996-09, Vol.112 (1), p.11-17

1996

Link zum Volltext

Verfügbarkeit prüfen

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Annals of oncology, 2019-08, Vol.30 (8), p.1404-1404

2019

Link zum Volltext

Verfügbarkeit prüfen

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Annals of oncology, 2018-07, Vol.29 (7), p.1607-1607

2018

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen for patients with estrogen receptor-negative breast cancer

Journal of clinical oncology, 2001-09, Vol.19 (18), p.93s-97s

SWAIN, Sandra M

2001

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1633-1642

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 5.988

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.869)
Mit Volltextzugriff
(5.428)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.431)
Life Sciences & Biomedicine
(2.030)
Humans
(1.264)
Physical Sciences
(1.078)
Technology
(890)
Female
(808)
Biological And Medical Sciences
(748)
Animals
(649)
Male
(570)
Physics
(531)
Medical Sciences
(520)
Engineering
(463)
Adult
(431)
Materials Science
(373)
Middle Aged
(335)
Exact Sciences And Technology
(312)
Engineering, Electrical & Electronic
(309)
Computer Science
(301)
Chemistry
(273)
Oncology
(263)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer

Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review

Modifications of a conserved regulatory network involving INDEHISCENT controls multiple aspects of reproductive tissue development in Arabidopsis

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy

Phase I trial of dasatinib and ixabepilone in patients with solid tumors

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

Altered Expression of SPINDLY Affects Gibberellin Response and Plant Development

The gar2 and rga Alleles Increase the Growth of Gibberellin-Deficient Pollen Tubes in Arabidopsis

Ductal Carcinoma In Situ, Complexities and Challenges

Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trial

Genetic analysis of gibberellin signal transduction

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Tamoxifen for patients with estrogen receptor-negative breast cancer

Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents

Suchergebnisse filtern